Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Authors
Keywords
-
Journal
Clinical Proteomics
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-29
DOI
10.1186/s12014-020-09285-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A unified model of dementias and age‐related neurodegeneration
- (2020) Michael Fossel Alzheimers & Dementia
- Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
- (2020) Bing Bai et al. NEURON
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
- (2020) Erik C. B. Johnson et al. NATURE MEDICINE
- Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage
- (2019) Eliska Jankovska et al. Clinical Proteomics
- Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard
- (2019) Maotian Zhou et al. JOURNAL OF PROTEOME RESEARCH
- Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease
- (2019) Annika Andersson et al. CLINICA CHIMICA ACTA
- Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
- (2019) Aliza P. Wingo et al. Nature Communications
- Undulating changes in human plasma proteome profiles across the lifespan
- (2019) Benoit Lehallier et al. NATURE MEDICINE
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Person-specific contribution of neuropathologies to cognitive loss in old age
- (2018) Patricia A. Boyle et al. ANNALS OF NEUROLOGY
- Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
- (2018) Erika Bereczki et al. BRAIN
- Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
- (2018) Ilijana Begcevic et al. Journal of Proteomics
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Alzheimer disease pathology and the cerebrospinal fluid proteome
- (2018) Loïc Dayon et al. Alzheimers Research & Therapy
- Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease
- (2018) Lingyan Ping et al. Scientific Data
- The Role of Osteopontin in Neurodegenerative Diseases
- (2018) Miryam Carecchio et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Dendritic spine remodeling accompanies Alzheimer’s disease pathology and genetic susceptibility in cognitively normal aging
- (2018) Benjamin D. Boros et al. NEUROBIOLOGY OF AGING
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
- (2018) Erik C. B. Johnson et al. Molecular Neurodegeneration
- Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease
- (2018) Gajanan Sathe et al. Proteomics Clinical Applications
- Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
- (2018) Bob Olsson et al. JAMA Neurology
- Revisiting biomarker discovery by plasma proteomics
- (2017) Philipp E Geyer et al. Molecular Systems Biology
- A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease
- (2017) Nicholas T. Seyfried et al. Cell Systems
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
- (2016) Nicolas R. Barthélemy et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
- (2016) Nicolas R Barthélemy et al. JOURNAL OF PROTEOME RESEARCH
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
- (2016) Ye Zhang et al. NEURON
- Advances in targeted proteomics and applications to biomedical research
- (2016) Tujin Shi et al. PROTEOMICS
- Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor β signalling and angiogenesis
- (2015) Khader Awwad et al. CARDIOVASCULAR RESEARCH
- Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays
- (2015) A. N. Hoofnagle et al. CLINICAL CHEMISTRY
- Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry
- (2015) Pauline Bros et al. Frontiers in Neuroscience
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
- (2014) Y. Zhang et al. JOURNAL OF NEUROSCIENCE
- Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics
- (2014) Navin Rauniyar et al. JOURNAL OF PROTEOME RESEARCH
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
- SMOC1 Is Essential for Ocular and Limb Development in Humans and Mice
- (2010) Ippei Okada et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- In-depth Exploration of Cerebrospinal Fluid by Combining Peptide Ligand Library Treatment and Label-free Protein Quantification
- (2010) Emmanuelle Mouton-Barbosa et al. MOLECULAR & CELLULAR PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now